Avanir Pharmaceuticals, Inc. is a leading specialty ...（Avanir制药公司是一家领先的专业）.pdf

Avanir Pharmaceuticals, Inc. is a leading specialty biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system (CNS) disorders of high unmet medical need. We are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. Investment Highlights Avanir Quick Facts NUEDEXTA® (dextromethorphan hydrobromide and quinidine sulfate) Headquarters: Aliso Viejo, CA Profitable Commercial Franchise Stock Listing: NASDAQ: AVNR Staff: Approximately 300 • Large market with a high unmet medical need; ~2 million patients in the U.S. • First and only FDA and EMA approved therapy for pseudobulbar affect (PBA), a Market Capitalization: $914 million* neurologic disorder causing sudden, disruptive outbursts of crying or laughing that Share Outstanding: 159.8 million** causes significant functional and quality-of-life impairment. Cash, cash equivalents restricted investments: o Occurs in patients with key neurological conditions including amyotrophic $56.5 million*** lateral sclerosis (ALS), multiple sclerosis (MS), stroke, tra